146 related articles for article (PubMed ID: 37890676)
1. Unusual conjunctival melanocytic proliferations. Report of five cases and review of the literature.
Eder A; Milman T; Mudhar HS; Lally SE; Shields CL; Bui K; Wells JR; Grossniklaus HE
Surv Ophthalmol; 2024; 69(2):230-240. PubMed ID: 37890676
[TBL] [Abstract][Full Text] [Related]
2. PRAME expression by immunohistochemistry and reverse transcription quantitative PCR in conjunctival melanocytic lesions-a comprehensive clinicopathologic study of 202 cases and correlation of cytogenetics with PRAME expression in challenging conjunctival melanocytic lesions.
Mudhar HS; Milman T; Stevenson S; Watson M; Kim J; Magan T; Salvi SM; Harley U; Lally SE; Shields CL
Hum Pathol; 2023 Apr; 134():1-18. PubMed ID: 36804828
[TBL] [Abstract][Full Text] [Related]
3. PRAME Expression in Junctional Melanocytic Proliferations of the Conjunctiva: A Potential Biomarker for Primary Acquired Melanosis/Conjunctival Melanocytic Intraepithelial Lesions.
Huang YY; Hrycaj SM; Chan MP; Stagner AM; Patel RM; Bresler SC
Am J Dermatopathol; 2022 Oct; 44(10):734-740. PubMed ID: 35475786
[TBL] [Abstract][Full Text] [Related]
4. PRAME immunohistochemistry is useful in the evaluation of conjunctival melanomas, nevi, and primary acquired melanosis.
LeBlanc RE; Miller DM; Zegans ME
J Cutan Pathol; 2021 Dec; 48(12):1442-1448. PubMed ID: 34089198
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical profiling including beta-catenin in conjunctival melanocytic lesions.
Reddy HS; Keene CD; Chang SH; Jian-Amadi A; Cimino PJ
Exp Mol Pathol; 2017 Apr; 102(2):198-202. PubMed ID: 28161440
[TBL] [Abstract][Full Text] [Related]
6. p16ink4a expression in benign and malignant melanocytic conjunctival lesions.
Zoroquiain P; Fernandes BF; González S; Novais GN; Schalper KA; Burnier MN
Int J Surg Pathol; 2012 Jun; 20(3):240-5. PubMed ID: 22287653
[TBL] [Abstract][Full Text] [Related]
7. WT1 and Bcl2 expression in melanocytic lesions of the conjunctiva: an immunohistochemical study of 123 cases.
Furusato E; Hidayat AA; Man YG; Auerbach A; Furusato B; Rushing EJ
Arch Ophthalmol; 2009 Aug; 127(8):964-9. PubMed ID: 19667332
[TBL] [Abstract][Full Text] [Related]
8. Distinction of conjunctival melanocytic nevi from melanomas by fluorescence in situ hybridization.
Busam KJ; Fang Y; Jhanwar SC; Pulitzer MP; Marr B; Abramson DH
J Cutan Pathol; 2010 Feb; 37(2):196-203. PubMed ID: 20100177
[TBL] [Abstract][Full Text] [Related]
9. Refining the application of PRAME-a useful marker in high CSD and acral melanoma subtypes.
Wakefield C; O'Keefe L; Heffron CCBB
Virchows Arch; 2023 Dec; 483(6):847-854. PubMed ID: 37723345
[TBL] [Abstract][Full Text] [Related]
10. Conjunctival Melanocytic Lesions.
Bresler SC; Simon C; Shields CL; McHugh JB; Stagner AM; Patel RM
Arch Pathol Lab Med; 2022 May; 146(5):632-646. PubMed ID: 34424954
[TBL] [Abstract][Full Text] [Related]
11. Melanocytic lesions of the conjunctiva.
Zembowicz A; Mandal RV; Choopong P
Arch Pathol Lab Med; 2010 Dec; 134(12):1785-92. PubMed ID: 21128776
[TBL] [Abstract][Full Text] [Related]
12. BAP1 and BRAFV600E expression in benign and malignant melanocytic proliferations.
Piris A; Mihm MC; Hoang MP
Hum Pathol; 2015 Feb; 46(2):239-45. PubMed ID: 25479927
[TBL] [Abstract][Full Text] [Related]
13. The usefulness of c-Kit in the immunohistochemical assessment of melanocytic lesions.
Pilloni L; Bianco P; Difelice E; Cabras S; Castellanos ME; Atzori L; Ferreli C; Mulas P; Nemolato S; Faa G
Eur J Histochem; 2011 Jun; 55(2):e20. PubMed ID: 22193299
[TBL] [Abstract][Full Text] [Related]
14. Melanocytic proliferations associated with lichen sclerosus.
Carlson JA; Mu XC; Slominski A; Weismann K; Crowson AN; Malfetano J; Prieto VG; Mihm MC
Arch Dermatol; 2002 Jan; 138(1):77-87. PubMed ID: 11790170
[TBL] [Abstract][Full Text] [Related]
15. Conjunctival melanocytic lesions in children.
McDonnell JM; Carpenter JD; Jacobs P; Wan WL; Gilmore JE
Ophthalmology; 1989 Jul; 96(7):986-93. PubMed ID: 2771364
[TBL] [Abstract][Full Text] [Related]
16. [Immunohistochemical markers for cytoplasmic antigens in acquired melanosis, malignant melanomas, and nevi of the conjunctiva].
Hitzer S; Bialasiewicz AA; Richard G
Klin Monbl Augenheilkd; 1998 Oct; 213(4):230-7. PubMed ID: 9848068
[TBL] [Abstract][Full Text] [Related]
17. HMB-45 immunohistochemical staining of conjunctival melanocytic lesions.
McDonnell JM; Sun YY; Wagner D
Ophthalmology; 1991 Apr; 98(4):453-8. PubMed ID: 1711186
[TBL] [Abstract][Full Text] [Related]
18. Pigmented conjunctival and scleral lesions.
Liesegang TJ
Mayo Clin Proc; 1994 Feb; 69(2):151-61. PubMed ID: 8309267
[TBL] [Abstract][Full Text] [Related]
19. Indeterminate melanocytic proliferations of the conjunctiva.
Grossniklaus HE; Margo CE; Solomon AR
Trans Am Ophthalmol Soc; 1999; 97():157-68; discussion 168-70. PubMed ID: 10703122
[TBL] [Abstract][Full Text] [Related]
20. Current appraisal of conjunctival melanocytic tumors: classification and treatment.
Harooni H; Schoenfield LR; Singh AD
Future Oncol; 2011 Mar; 7(3):435-46. PubMed ID: 21417906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
